Palliative Care for Parkinson's Disease
(COPE-PD Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to learn more about the effectiveness of palliative care training for community physicians and telemedicine support services for patients and carepartners with Parkinson's disease and Lewy Body Dementia (LBD) or related conditions and their care partners. Palliative care is a treatment approach focused on improving quality of life by relieving suffering in the areas of physical symptoms such as pain, psychiatric symptoms such as depression, psychosocial issues and spiritual needs. Telemedicine is the use of technology that allows participants to interact with a health care provider without being physically near the provider.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Online Community-Supported Palliative Care, Community-Based Palliative Care, Telehealth Palliative Care, Online Palliative Support for Parkinson's Disease?
Is telehealth palliative care safe for humans?
The research on telehealth palliative care, which includes methods like video conferencing and online platforms, suggests it is generally safe and well-received by patients, caregivers, and providers. It has been used effectively for monitoring symptoms and managing care, with positive experiences reported in most studies.678910
How does palliative care differ from other treatments for Parkinson's disease?
Palliative care for Parkinson's disease is unique because it focuses on improving quality of life by addressing physical, psychological, social, and spiritual issues from the time of diagnosis, rather than just treating symptoms. It can be delivered through telehealth, increasing access for those in under-resourced areas or who are homebound, and involves a team approach that includes specialists to handle complex issues.2351112
Research Team
Benzi Kluger, MD
Principal Investigator
University of Rochester
Eligibility Criteria
This trial is for people over 40 with Parkinson's disease or related conditions like progressive supranuclear palsy, multiple system atrophy, and Lewy Body Dementia. It's not for those who can't commit to the study, need palliative care for other illnesses like advanced cancer, or are already receiving palliative or hospice care.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Data Collection
Baseline data collection for usual care practices before intervention begins
Intervention
Community neurologists receive palliative care training and patients access online support services
Follow-up
Participants are monitored for quality of life and caregiver burden
Treatment Details
Interventions
- Online Community-Supported Palliative Care (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
University of Colorado, Denver
Collaborator
Stanford University
Collaborator
Massachusetts General Hospital
Collaborator